Glutamate/glutamine and neuronal integrity in adults with ADHD: A proton MRS study

Translational Psychiatry

Volumn 4, Issue 3, 2014, Pages

  Maltezos, S ^a,b   Horder, J ^b   Coghlan, S ^b   Skirrow, C ^b   O'Gorman, R ^b   Lavender, T J ^b   Mendez, M A ^b,c   Mehta, M ^b   Daly, E ^b   Xenitidis, K ^a,b   Paliokosta, E ^a   Spain, D ^b,c   Pitts, M ^a   Asherson, P ^a,b   Lythgoe, D J ^b   Barker, G J ^b   Murphy, D G ^b,c  

^a SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BETHLEM ROYAL HOSPITAL   (United Kingdom)

Author keywords

ADHD; Basal ganglia; Dorsolateral prefrontal cortex; Magnetic resonance spectroscopy; Parietal lobe

Indexed keywords

CHOLINE; CREATINE; DEXAMPHETAMINE; GLUTAMIC ACID; GLUTAMINE; METHYLPHENIDATE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NERVE CELL; PARIETAL CORTEX; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROCEDURES;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BASAL GANGLIA; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PREFRONTAL CORTEX;

EID: 84922531130     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.11     Document Type: Article

References (45)

1. Simon V, Czobor P, Balint S, Meszaros A, Bitter I. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry 2009; 194: 204-211.
2. Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugue M, Carpentier PJ et al. European consensus statement on diagnosis and treatment of adult ADHD: the European Network adult ADHD. BMC Psychiatry 2010; 10: 67.
3. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr 2012; 12: 78.
4. Paloyelis Y, Mehta MA, Kuntsi J, Asherson P. Functional MRI in ADHD: a systematic literature review. Exp Rev Neurother 2007; 7: 1337-1356.
5. van der Kooij MA, Glennon JC. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci Biobehav Rev 2007; 31: 597-618.
6. Swanson JM, Kinsbourne M, Nigg J, Lanphear B, Stefanatos GA, Volkow N et al. Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychol Rev 2007; 17: 39-59.
7. Heal DJ, Cheetham SC, Smith SL. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology 2009; 57: 608-618.
8. Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X et al. Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis. CNS Drugs 2011; 25: 157-169.
9. Steele M, Jensen PS, Quinn DM. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther 2006; 28: 1892-1908.
10. Adler LA, Kroon RA, Stein M, Shahid M, Tarazi FI, Szegedi A et al. A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator Org 26576 in adult attention-deficit/hyperactivity disorder. Biol Psychiatry 2012; 72: 971-977.
11. Petroff OA. GABA and glutamate in the human brain. Neuroscientist 2002; 8: 562-573.
12. Karreman M, Moghaddam B. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem 1996; 66: 589-598.
13. Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 2007; 6: 444-452.
14. Warton FL, Howells FM, Russell VA. Increased glutamate-stimulated release of dopamine in substantia nigra of a rat model for attention-deficit/hyperactivity disorder-lack of effect of methylphenidate. Metab Brain Dis 2009; 24: 599-613.
15. van der Graaf M. In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. Eur Biophys J 2010; 39: 527-540.
16. Hesslinger B, Thiel T, Tebartz van Elst L, Hennig J, Ebert D. Attention-deficit disorder in adults with or without hyperactivity: where is the difference? A study in humans using short echo (1)H-magnetic resonance spectroscopy. Neurosci Lett 2001; 304: 117-119.
17. Dramsdahl M, Ersland L, Plessen KJ, Haavik J, Hugdahl K, Specht K. Adults with attention-deficit/hyperactivity disorder-a brain magnetic resonance spectroscopy study. Front Psychiatry 2011; 2: 65.
18. Perlov E, Tebarzt van Elst L, Buechert M, Maier S, Matthies S, Ebert D et al. H(1)-MR-spectroscopy of cerebellum in adult attention deficit/hyperactivity disorder. J Psychiatr Res 2010; 44: 938-943.
19. Perlov E, Philipsen A, Hesslinger B, Buechert M, Ahrendts J, Feige B et al. Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder-a magnet resonance spectroscopy study. J Psychiatr Res 2007; 41: 934-941.
20. Wiguna T, Guerrero AP, Wibisono S, Sastroasmoro S. Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS). Clin Neuropharmacol 2012; 35: 81-85.
21. Valera EM, Faraone SV, Murray KE, Seidman LJ. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol Psychiatry 2007; 61: 1361-1369.
22. Cools R, Clark L, Robbins TW. Differential responses in human striatum and prefrontal cortex to changes in object and rule relevance. J Neurosci 2004; 24: 1129-1135.
23. Cools R, Ivry RB, D'Esposito M. The human striatum is necessary for responding to changes in stimulus relevance. J Cogn Neurosci 2006; 18: 1973-1983.
24. Wager TD, Jonides J, Reading S. Neuroimaging studies of shifting attention: a meta-analysis. Neuroimage 2004; 22: 1679-1693.
25. Adler CM, Sax KW, Holland SK, Schmithorst V, Rosenberg L, Strakowski SM. Changes in neuronal activation with increasing attention demand in healthy volunteers: an fMRI study. Synapse 2001; 42: 266-272.
26. Epstein JN, Johnson DE, Conners CK. Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID). Multi-Health Systems, Inc.: North Tonawanda, NY, USA, 1999.
27. Barkley RA, Murphy KR. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment2nd edn.Guilford Press: New York, USA, 1998.
28. Horder J, Lavender T, Mendez MA, O'Gorman R, Daly E, Craig MC et al. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1) H]MRS study. Transl Psychiatry 2013; 3: e279.
29. Murphy DG, Critchley HD, Schmitz N, McAlonan G, Van Amelsvoort T, Robertson D et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002; 59: 885-891.
30. Page LA, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006; 163: 2189-2192.
31. MacMaster FP, Carrey N, Sparkes S, Kusumakar V. Proton spectroscopy in medication-free pediatric attention-deficit/hyperactivity disorder. Biol Psychiatry 2003; 53: 184-187.
32. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci 2004; 16: 63-69.
33. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M et al. Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 2006; 163: 316-318.
34. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007; 17: 11-17.
35. Yeo RA, Hill DE, Campbell RA, Vigil J, Petropoulos H, Hart B et al. Proton magnetic resonance spectroscopy investigation of the right frontal lobe in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42: 303-310.
36. Sun L, Jin Z, Zang YF, Zeng YW, Liu G, Li Y et al. Differences between attentiondeficit disorder with and without hyperactivity: a 1H-magnetic resonance spectroscopy study. Brain Dev 2005; 27: 340-344.
37. Elia J, Glessner JT, Wang K, Takahashi N, Shtir CJ, Hadley D et al. Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder. Nat Genet 2011; 44: 78-84.
38. Russell VA. Dopamine hypofunction possibly results from a defect in glutamatestimulated release of dopamine in the nucleus accumbens shell of a rat model for attention deficit hyperactivity disorder-the spontaneously hypertensive rat. Neurosci Biobehav Rev 2003; 27: 671-682.
39. Ferreira PE, Palmini A, Bau CH, Grevet EH, Hoefel JR, Rohde LA et al. Differentiating attention-deficit/hyperactivity disorder inattentive and combined types: a (1)Hmagnetic resonance spectroscopy study of fronto-striato-thalamic regions. J Neural Transm 2009; 116: 623-629.
40. Surmeier DJ, Ding J, Day M, Wang Z, Shen W. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons. Trends Neurosci 2007; 30: 228-235.
41. Moffett JR, Ross B, Arun P, Madhavarao CN, Namboodiri AM. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol 2007; 81: 89-131.
42. Magistretti PJ, Pellerin L. Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders. Ann NY Acad Sci 1996; 777: 380-387.
43. Zametkin AJ, Nordahl TE, Gross M, King AC, Semple WE, Rumsey J et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323: 1361-1366.
44. Albrecht J, Sidoryk-Wegrzynowicz M, Zielinska M, Aschner M. Roles of glutamine in neurotransmission. Neuron Glia Biol 2010; 6: 263-276.
45. Christakou A, Murphy CM, Chantiluke K, Cubillo AI, Smith AB, Giampietro V et al. Disorder-specific functional abnormalities during sustained attention in youth with attention deficit hyperactivity disorder (ADHD) and with autism. Mol Psychiatry 2012; 18: 236-244.